Table 2 Initial findings on CMR

LVEF at diagnosis, %

57.0 ± 9.0

LVEDV at diagnosis, ml/m²

72.9 ± 18.0

Patients with pericardial effusion (N,%)

58 (28.4)

Patients with asynergic myocardial segments (N,%)

39 (19)

LGE

Number of patients with LGE (N,%)

203 (100)

Number of segments with LGE, N

3.8 ± 2.2

Myocardial extent of LGE (% myocardial surface area)

11.4 ± 7.0

Nodular Pattern (N,%)

150 (73.5)

Sub-epicardial lesions (N,%)

168 (82.3)

Midwall lesions (N,%)

33 (16.1)

Transmural lesions (N,%)

2 (1.0)

Presence of LGE in opposed walls (N,%)

77 (38.0)

Postero-lateral localization (N,%)

122 (60)

Anterior wall involved (N,%)

17 (8.3)

Postero-lateral and septal localisation (N,%)

60 (29.4)

Hyper T2 signal

Number of patients with hyper T2 (N,%)

100 (62.5)

Number of segments with hyper T2 signal

1.9 ± 1.8

Myocardial extent of Hyper T2 (% myocardial surface area)

10.9 ± 5.7

Presence of T2 hyper-signal in opposed walls (N,%)

34 (21.2)

EGE

Number of patients with EGE (N,%)

114 (56)

Number of segments with EGE

1.8 ± 1.9

Myocardial extent of EGE (% myocardial surface area)

8.6 ± 5.4

Presence of local EGE in opposed walls (N,%)

30 (14.7)